Women’s health startup Ovum has successfully raised $4 million in a Seed funding round, valuing the company at $18 million. The investment was led by Admiralty Capital Group, with contributions from several other investors including Antler and Giant Leap. The funds are earmarked for enhancing AI capabilities and developing comprehensive data sets focused on women’s health. Ovum’s AI technology aims to track symptoms, lifestyle, and medical data to identify health patterns, assisting women in their healthcare journey. Since its launch, the app has seen significant growth, with over 20,000 downloads and 107,000 AI-driven health interactions. Founder Dr. Ariella Heffernan-Marks, motivated by her own health experiences, emphasizes the importance of creating a healthcare system that truly supports women’s needs. Ovum is also partnering with organizations like Medibank and undertaking clinical trials to further explore AI’s role in women’s health. Admiralty Capital Group praises Ovum’s mission and potential for global impact.
Has Ovum secured $4 million in Seed funding for women’s health data?
